Skip to main content
Clinical Trials/CTRI/2021/09/036171
CTRI/2021/09/036171Not yet recruiting未知

Clinical profile and outcome of acute kidney injury in chronic liver disease: Role of novel biomarker NGAL in differential diagnosis of acute kidney injury

Kasturba Medical College0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • Clinically diagnosed with cirrhosis of
  • the liver with AKI as per
  • ICA criteria

Exclusion Criteria

  • Kidney or liver transplant
  • Chronic hemodialysis before admission
  • or receiving nephrotoxic medications.
  • Chronic kidney disease
  • Renal insufficiency or urinary obstruction
  • Hepatocellular carcinoma or any other
  • advanced malignancy
  • UTI (Urinary tract infection)
  • (Positive urine culture or urine WBC > 10
  • per high power field)
  • Septic shock
  • Lack of informed consent

Investigators

Similar Trials